Advertisement
UK markets closed
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     
  • CRUDE OIL

    83.02
    +1.12 (+1.37%)
     
  • GOLD FUTURES

    2,343.50
    -2.90 (-0.12%)
     
  • DOW

    38,472.19
    +232.21 (+0.61%)
     
  • Bitcoin GBP

    53,580.22
    +272.02 (+0.51%)
     
  • CMC Crypto 200

    1,435.80
    +21.04 (+1.49%)
     
  • NASDAQ Composite

    15,667.82
    +216.52 (+1.40%)
     
  • UK FTSE All Share

    4,378.75
    +16.15 (+0.37%)
     

Why Clovis' Good News In Ovarian Cancer Prodded These Rivals Down

Why Clovis' Good News In Ovarian Cancer Prodded These Rivals Down

Clovis rose Wednesday to the detriment of Tesaro and AstraZeneca after the FDA accepted its application for expanded use of its PARP inhibitor known as Rubraca.